These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 27161592)

  • 1. The relationship between valproate induced tremors and circulating neurotransmitters: a preliminary study.
    Hamed SA; Abdellah MM
    Int J Neurosci; 2017 Mar; 127(3):236-242. PubMed ID: 27161592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computerized tremor analysis of valproate-induced tremor: a comparative study of controlled-release versus conventional valproate.
    Rinnerthaler M; Luef G; Mueller J; Seppi K; Wissel J; Trinka E; Bauer G; Poewe W
    Epilepsia; 2005 Feb; 46(2):320-3. PubMed ID: 15679514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and surface EMG characteristics of valproate induced tremors.
    Mehndiratta MM; Satyawani M; Gupta S; Khwaja GA
    Electromyogr Clin Neurophysiol; 2005; 45(3):177-82. PubMed ID: 15981690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disabling Resting Tremors Induced by the Short-term Infusion of Valproate: A Reversible Phenomenon.
    Gupta A; Kushwaha S
    Tremor Other Hyperkinet Mov (N Y); 2018; 8():615. PubMed ID: 30619645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose sodium valproate in the treatment of idiopathic generalized epilepsies.
    Miró J; Aiguabella M; Veciana M; Juvany R; Santurino M; Leiva E; Salas-Puig J; Falip M
    Acta Neurol Scand; 2014 May; 129(5):e20-3. PubMed ID: 24372179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-related metabolic changes during treatment with valproate in patients with epilepsy.
    Pylvänen V; Pakarinen A; Knip M; Isojärvi J
    Epilepsy Behav; 2006 May; 8(3):643-8. PubMed ID: 16600693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valproic acid-induced nocturnal enuresis in pediatric patients.
    Ozan K; Coskun Y; Bora CK; Ayten Y
    Niger J Clin Pract; 2019 Jan; 22(1):108-112. PubMed ID: 30666028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating levels of allopregnanolone, a neuroactive steroid, and leptin during treatment with valproic acid in children with epilepsy.
    Grosso S; Luisi S; Mostardini R; Matera M; Barlocco EG; Casarosa E; Balestri P; Petraglia F
    Neuroendocrinology; 2011; 93(3):159-64. PubMed ID: 20980729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced anticonvulsant efficacy of valproic acid in dopamine beta-hydroxylase knockout mice.
    Schank JR; Liles LC; Weinshenker D
    Epilepsy Res; 2005 Jun; 65(1-2):23-31. PubMed ID: 15955669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical characteristics and related factors of tremor in patients with epilepsy.
    Xiao Y; Xiong W; Lu L; Chen J; Zhang Y; Jiang X; Zhou D
    Seizure; 2019 Mar; 66():70-75. PubMed ID: 30807902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weight and fat distribution in patients taking valproate: a valproate-discordant gender-matched twin and sibling pair study.
    Petty SJ; Kantor S; Lawrence KM; Berkovic SF; Collins M; Hill KD; Makovey J; Sambrook PN; O'Brien TJ; Wark JD
    Epilepsia; 2014 Oct; 55(10):1551-7. PubMed ID: 25124647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic syndrome and anticonvulsants: A comparative study of valproic acid and carbamazepine.
    Rakitin A; Kõks S; Haldre S
    Seizure; 2016 May; 38():11-6. PubMed ID: 27061880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term treatment with sodium valproate: monitoring of venous ammonia concentrations and adverse effects.
    Zaccara G; Campostrini R; Paganini M; Messori A; Valenza T; Arnetoli G; Zappoli R
    Ther Drug Monit; 1987; 9(1):34-40. PubMed ID: 3107169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variants p.Q1236H and p.E1143G in mitochondrial DNA polymerase gamma POLG1 are not associated with increased risk for valproate-induced hepatotoxicity or pancreatic toxicity: A retrospective cohort study of patients with epilepsy.
    Hynynen J; Pokka T; Komulainen-Ebrahim J; Myllynen P; Kärppä M; Pylvänen L; Kälviäinen R; Sokka A; Jyrkilä A; Lähdetie J; Haataja L; Mäkitalo A; Ylikotila P; Eriksson K; Haapala P; Ansakorpi H; Hinttala R; Vieira P; Majamaa K; Rantala H; Uusimaa J
    Epilepsia; 2018 Nov; 59(11):2125-2136. PubMed ID: 30255931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conversion from delayed-release sodium valproate to extended-release sodium valproate: initial results and long-term follow-up.
    McCabe PH; Michel NC; McNew CD; Lehman EB
    Epilepsy Behav; 2006 May; 8(3):601-5. PubMed ID: 16678766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valproate teratogenicity and epilepsy syndrome.
    Bromfield EB; Dworetzky BA; Wyszynski DF; Smith CR; Baldwin EJ; Holmes LB
    Epilepsia; 2008 Dec; 49(12):2122-4. PubMed ID: 18557775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valproate-induced thrombocytopenia: a prospective monotherapy study.
    Nasreddine W; Beydoun A
    Epilepsia; 2008 Mar; 49(3):438-45. PubMed ID: 18031547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. States of serum leptin and insulin in children with epilepsy: risk predictors of weight gain.
    Hamed SA; Fida NM; Hamed EA
    Eur J Paediatr Neurol; 2009 May; 13(3):261-8. PubMed ID: 18586538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse effects of carbamazepine, phenytoin, valproate and lamotrigine monotherapy in epileptic adult Chinese patients.
    Zeng K; Wang X; Xi Z; Yan Y
    Clin Neurol Neurosurg; 2010 May; 112(4):291-5. PubMed ID: 20071075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The risk of asymptomatic hyperammonemia in children with idiopathic epilepsy treated with valproate: relationship to blood carnitine status.
    Hamed SA; Abdella MM
    Epilepsy Res; 2009 Sep; 86(1):32-41. PubMed ID: 19446440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.